摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-O-acetylresveratrol

中文名称
——
中文别名
——
英文名称
3-O-acetylresveratrol
英文别名
[3-Hydroxy-5-[2-(4-hydroxyphenyl)ethenyl]phenyl] acetate
3-O-acetylresveratrol化学式
CAS
——
化学式
C16H14O4
mdl
——
分子量
270.285
InChiKey
FATXNQWLANBPPI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    66.8
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    3,5,4'-tri-O-acetylresveratrolresveratrolpotassium carbonate 作用下, 以 二甲基亚砜 为溶剂, 反应 2.0h, 以76%的产率得到3,5-di-O-acetylresveratrol
    参考文献:
    名称:
    利用固有亲核试剂通过分子间合作酯交换反应进行多酚的区域选择性O酰化
    摘要:
    已经开发了一种绿色有效的多酚区域选择性O-酰化方法。可以在温和条件下通过分子间合作酯交换利用“固有亲核试剂”,在碳酸钾/二甲亚砜体系中进行酰化反应。该方法在带有2',4'-二羟基苯乙酮部分的多酚的区域选择性酰化中显示出特别的优势,并且可以扩展为不具有该部分的多酚的单乙酸酯或多种乙酸酯的合成。与其他已报道的方法相比,该方法具有原子经济性,并且在避免使用任何金属基催化剂方面更加环保。
    DOI:
    10.1016/j.tet.2016.05.048
点击查看最新优质反应信息

文献信息

  • Novel Sirtuin Activating Compounds and Methods for Making the Same
    申请人:Andrus Merritt B.
    公开号:US20080255382A1
    公开(公告)日:2008-10-16
    The present invention includes methods for preparing resveratrol, resveratrol esters and substituted and unsubstituted stilbenes of the formula given below; where each Y is —O or halogen, each Z is —O or halogen, each n and each m is independently the value of 0, 1, 2, 3, 4 or 5, each A and each B is independently selected from P n , R or absent, each V and each W is independently selected from P n , straight or branched alkyl of from (2) to (6) carbon atoms and cycloalkyl of from (3) to (8) carbon atoms, alkoxy, phenyl, benzyl or halogen, R is independently selected from the group comprising alkyl with at least one carbon atom, aryl and aralkyl, P n is an alcohol protecting group and diastereoisomers of the foregoing. The compounds are made from a multi-step process including a N-heterocyclic carbon-type ligand coupling in the presence of a base with benzyol halide and styrene coupling partners. These compounds show increased stability for use in the food, cosmetic and pharmaceutical industries.
    本发明涉及一种制备白藜芦醇、白藜芦醇酯和给定以下结构式的取代和未取代的stilbenes的方法;其中每个Y是—O或卤素,每个Z是—O或卤素,每个n和每个m独立地取值为0、1、2、3、4或5,每个A和每个B独立地从Pn、R或缺席中选择,每个V和每个W独立地从Pn、由(2)到(6)个碳原子的直链或支链烷基和由(3)到(8)个碳原子的环烷基、烷氧基、苯基、苄基或卤素中选择,R独立地从包括至少一个碳原子的烷基、芳基和芳基烷基的群体中选择,Pn是醇保护基和上述化合物的对映异构体。这些化合物是通过多步过程制备的,其中包括在碱存在下与苄基卤和苯乙烯偶联合成N-杂环碳型配体偶联。这些化合物在食品、化妆品和制药行业中显示出增强的稳定性。
  • Compositions for manipulating the lifespan and stress response of cells and organisms
    申请人:Howitz T. Konrad
    公开号:US20060084135A1
    公开(公告)日:2006-04-20
    Provided herein are methods and compositions for modulating the activity of sirtuin deacetylase protein family members; p53 activity; apoptosis; lifespan and sensitivity to stress of cells and organisms. Exemplary methods comprise contacting a cell with an activating compound, such as a flavone, stilbene, flavanone, isoflavone, catechin, chalcone, tannin or anthocyanidin; or an inhibitory compound, such as a sphingolipid, e.g., sphingosine.
    本文提供了一种调节sirtuin去乙酰化酶蛋白家族成员、p53活性、细胞和生物的凋亡、寿命和对压力敏感性的方法和组合物。其中一种示例方法包括使用活化化合物(如黄酮、双苯乙烯、黄烷酮、异黄酮、儿茶素、查尔酮、单宁或花青素)或抑制化合物(如鞘脂类化合物,例如鞘氨醇)与细胞接触。
  • NOVEL SIRTUIN ACTIVATING COMPOUNDS AND PROCESSES FOR MAKING THE SAME
    申请人:Andrus Merritt B.
    公开号:US20100185006A1
    公开(公告)日:2010-07-22
    The present invention includes methods for preparing resveratrol, resveratrol esters and substituted and unsubstituted stilbenes of the formula given below; where each Y is —O or halogen, each Z is —O or halogen, each n and each m is independently the value of 0, 1, 2, 3, 4 or 5, each A and each B is independently selected from P n , R or absent, each V and each W is independently selected from P n , straight or branched alkyl of from 2 to 6 carbon atoms and cycloalkyl of from 3 to 8 carbon atoms, alkoxy, phenyl, benzyl or halogen, R is independently selected from the group comprising alkyl with at least one carbon atom, aryl and aralkyl, P n is an alcohol protecting group and diastereoisomers of the foregoing. The compounds are made from a multi-step process including a N-heterocyclic carbene-type ligand coupling in the presence of a base with benzyol halide and styrene coupling partners. These compounds show increased stability for use in the food, cosmetic and pharmaceutical industries.
    本发明涉及制备白藜芦醇、白藜芦醇酯和给出下列式子的取代和未取代的苯乙烯的方法;其中每个Y是—O或卤素,每个Z是—O或卤素,每个n和每个m是独立地取值为0、1、2、3、4或5,每个A和每个B是独立地从Pn、R或缺失中选择,每个V和每个W是独立地从Pn、2到6个碳原子的直链或支链烷基和3到8个碳原子的环烷基、烷氧基、苯基、苄基或卤素中选择,R是独立地从包括至少一个碳原子的烷基、芳基和芳基烷基的群体中选择,Pn是醇保护基和上述化合物的对映异构体。这些化合物是通过多步反应制备的,包括在碱存在下与苯乙烯偶联反应的N-杂环卡宾型配体偶联反应。这些化合物表现出增强的稳定性,可用于食品、化妆品和制药工业中。
  • SIRT1 modulators for manipulating cell/organism lifespan/stress response
    申请人:President and Fellows of Harvard College
    公开号:EP2289504A2
    公开(公告)日:2011-03-02
    Provided herein are methods and compositions for modulating the activity of sirtuin deacetylase protein family members; p53 activity; apoptosis; lifespan and sensitivity to stress of cells and organisms. Exemplary methods comprise contacting a cell with an activating compound, such as a flavone, stilbene, flavanone, isoflavone, catechin, chalcone, tannin or anthocyanidin; or an inhibitory compound, such as a sphingolipid, e.g., sphingosine.
    本文提供了用于调节 sirtuin 去乙酰化酶家族成员活性、p53 活性、细胞凋亡、寿命以及细胞和生物体对应激的敏感性的方法和组合物。示例性方法包括使细胞与激活化合物接触,如黄酮、链烯、黄烷酮、异黄酮、儿茶素、查尔酮、单宁或花青素;或与抑制化合物接触,如鞘磷脂,如鞘磷脂。
  • Formulation and process for modulating wound healing
    申请人:BioMendics, LLC
    公开号:US10426742B2
    公开(公告)日:2019-10-01
    Methods and compounds are disclosed for wound healing by modulating autophagy. A formulation for modulating autophagy comprises a first modulating compound (FAM) selected from compounds having the general structure (I): wherein: L represents a linker selected from —C≡C—, (a tolan), —CH═CH— (a stilbene, preferably trans); or —CRa═CRb— a stilbene derivative; where Ra and Rb are independently H or phenyl optionally substituted with —(R3)p or —(R4)q; R1 to R4 are independent substituents at any available position of the phenyl rings, preferably at 3, 3′, 4, 4′, and/or 5, 5′; and m, n, p, and q are independently 0, 1, 2, or 3 representing the number of substituents of the rings, respectively, but at least one of m or n must be ≥1. Each R1 to R2 is independently selected from substituents described herein, including but not limited to hydroxyl, alkoxy, halo, halomethyl and glycosides. The formulation may also include an auxiliary autophagy modulating compound (AAM) as described herein. The formulation may include a hydrogel formed by the compounds themselves or otherwise and may include salts and/or complexes.
    本发明公开了通过调节自噬促进伤口愈合的方法和化合物。用于调节自噬的制剂包括选自具有一般结构 (I) 的化合物的第一调节化合物 (FAM): 其中L 代表选自-C≡C-(甲苯)、-CH═CH-(二苯乙烯,最好是反式)或-CRa═CRb-二苯乙烯衍生物的连接体;其中 Ra 和 Rb 独立地是 H 或任选被-(R3)p 或-(R4)q 取代的苯基; R1至R4是独立的取代基,位于苯基环的任何可用位置,优选位于3,3′、4,4′和/或5,5′;m、n、p和q分别独立地为0、1、2或3,代表环的取代基数目,但m或n中至少有一个必须≥1。每个 R1 至 R2 独立地选自本文所述的取代基,包括但不限于羟基、烷氧基、卤代、卤代甲基和苷。制剂还可包括本文所述的辅助自噬调节化合物(AAM)。制剂可包括由化合物本身或以其它方式形成的水凝胶,并可包括盐和/或复合物。
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 银松素 铒(III) 离子载体 I 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯 钠3-(4-甲氧基苯基)-2-苯基丙烯酸酯 重氮基乙酸胆酯酯 醋酸(R)-(+)-2-羟基-1,2,2-三苯乙酯 酸性绿16 邻氯苯基苄基酮 那碎因盐酸盐 那碎因[鹼] 达格列净杂质54 辛那马维林 赤藓型-1,2-联苯-2-(丙胺)乙醇 赤松素 败脂酸,丁基丙-2-烯酸酯,甲基2-甲基丙-2-烯酸酯,2-甲基丙-2-烯酸